Document is current
Any future updates will be listed below
-
Authors
Lapi, Francesco https://orcid.org/0000-0002-4342-9128
Marconi, Ettore
Aprile, Pierangelo Lora
Magni, Alberto
Vetrano, Davide Liborio
Rossi, Alessandro
Pilotto, Alberto
Cricelli, Claudio
-
Funding
Funding for this research was provided by:
Società Italiana di Medicina Generale e delle Cure Primarie
- License Information
-
More Information
Article History
Received: 10 May 2024
Accepted: 28 October 2024
First Online: 19 December 2024
Declarations
:
: FL and EM provided consultancies in protocol preparation for epidemiological studies and data analyses for Viatris, Abbott Nutrition, and Abiogen. PLA, AM, AR and CC provided clinical consultancies for Viatris, Abbott Nutrition, and Abiogen. DLV and AP have no conflict of interest to disclose.
: According to a by-law on the classification and implementation of observational drug-related research, as issued by the Italian National Drug Agency (an entity belonging to the Italian Ministry of Health), the present study does not require approval by an Ethics Committee in Italy (Italian Drug Agency note of 3 August 2007). This study followed the principles of the Declaration of Helsinki and compliant with the STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) guidelines.
: Not Applicable.
